Global Partners Unite to Fund High-Risk, High-Reward Cancer Science - Cancer Grand Challenges
The One Vaccine That Could Save a Generation of Indian Women
$1M AI Accelerator Grant for Ovarian Cancer Research - Ovarian Cancer Research Alliance
Marty Makary: Approved a MM Drug Just 55 Days After the Application Was Filed
SURE-02 Trial: Neoadjuvant Sacituzumab Govitecan + Pembrolizumab in Muscle-Invasive Bladder Cancer
CART19-BE-02 trial: From Bench to Bedside and Beyond - Resonance
Prof. Gevorg Tamamyan Joins the London Global Cancer Week Steering Group
LITESPARK-022 Update: Adjuvant Belzutifan + Pembrolizumab in High-Risk Clear Cell Renal Cell Carcinoma
